New data show benefit of tiotropium/olodaterol Respimat ® from the start of COPD maintenance therapy

New data show benefit of tiotropium/olodaterol Respimat ® from the start of COPD maintenance therapy
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news